118 related articles for article (PubMed ID: 37098873)
1. Analysis of non-targeted serum metabolomics in patients with chronic kidney disease and hyperuricemia.
Yang WY; Wang J; Li XH; Xu B; Yang YW; Yu L; Zhang B; Feng JF
Biotechnol Genet Eng Rev; 2023 Apr; ():1-27. PubMed ID: 37098873
[TBL] [Abstract][Full Text] [Related]
2. Targeted and non-targeted metabolomics uncovering the effects of Er-Miao-Wan formula on rats with hyperuricemia.
Gu C; Hu X; Shan B; Wu X; Chen J
J Pharm Biomed Anal; 2023 Mar; 226():115246. PubMed ID: 36731256
[TBL] [Abstract][Full Text] [Related]
3. High-Throughput Untargeted Serum Metabolomics Analysis of Hyperuricemia Patients by UPLC-Q-TOF/MS.
Qin N; Jiang Y; Shi W; Wang L; Kong L; Wang C; Guo Y; Zhang J; Ma Q
Evid Based Complement Alternat Med; 2021; 2021():5524772. PubMed ID: 34234835
[TBL] [Abstract][Full Text] [Related]
4. NMR spectroscopy based metabolomics confirms the aggravation of metabolic disorder in metabolic syndrome combined with hyperuricemia.
Zhang Y; Zhang H; Rong S; Bian C; Yang Y; Pan H
Nutr Metab Cardiovasc Dis; 2021 Jul; 31(8):2449-2457. PubMed ID: 34154888
[TBL] [Abstract][Full Text] [Related]
5. Metabolic pathway analysis of hyperuricaemia patients with hyperlipidaemia based on high-throughput mass spectrometry: a case‒control study.
Wei X; Jia X; Liu R; Zhang S; Liu S; An J; Zhou L; Zhang Y; Mo Y; Li X
Lipids Health Dis; 2022 Dec; 21(1):151. PubMed ID: 36585694
[TBL] [Abstract][Full Text] [Related]
6. [Plasma metabolomics in a deep vein thrombosis rat model based on ultra-high performance liquid chromatography-electrostatic field orbitrap high resolution mass spectrometry].
Gu Y; Zang P; Li J; Yan Y; Wang J
Se Pu; 2022 Aug; 40(8):736-745. PubMed ID: 35903841
[TBL] [Abstract][Full Text] [Related]
7. Rapid identification of early renal damage in asymptomatic hyperuricemia patients based on urine Raman spectroscopy and bioinformatics analysis.
Kong X; Liang H; An W; Bai S; Miao Y; Qiang J; Wang H; Zhou Y; Zhang Q
Front Chem; 2023; 11():1045697. PubMed ID: 36762194
[No Abstract] [Full Text] [Related]
8. The Bidirectional Relationship between Chronic Kidney Disease and Hyperuricemia: Evidence from a Population-Based Prospective Cohort Study.
Ma Z; Wang X; Zhang J; Yang C; Du H; Dou F; Li J; Zhao Y; Quan P; Hu X
Int J Environ Res Public Health; 2023 Jan; 20(3):. PubMed ID: 36767097
[TBL] [Abstract][Full Text] [Related]
9. Alterations of gut microbiota and metabolome in early chronic kidney disease patients complicated with hyperuricemia.
Liu P; Yang J; Chen Y; Zhu Y; Tang Y; Xu X; He H
Heliyon; 2023 Sep; 9(9):e20328. PubMed ID: 37809388
[TBL] [Abstract][Full Text] [Related]
10. A metabonomic study to explore potential markers of asymptomatic hyperuricemia and acute gouty arthritis.
Wang W; Kou J; Zhang M; Wang T; Li W; Wang Y; Xie Q; Wei M
J Orthop Surg Res; 2023 Feb; 18(1):96. PubMed ID: 36782295
[TBL] [Abstract][Full Text] [Related]
11. Clinical classification of hyperuricemia in patients with chronic kidney disease.
Li F; Guo H; Zou J; Fu C; Liu S; Xiao J; Ye Z
Int Urol Nephrol; 2021 Aug; 53(8):1665-1674. PubMed ID: 33387225
[TBL] [Abstract][Full Text] [Related]
12. Serum lipidomics reveals distinct metabolic profiles for asymptomatic hyperuricemic and gout patients.
Liu S; Wang Y; Liu H; Xu T; Wang MJ; Lu J; Guo Y; Chen W; Ke M; Zhou G; Lu Y; Chen P; Zhou W
Rheumatology (Oxford); 2022 May; 61(6):2644-2651. PubMed ID: 34599805
[TBL] [Abstract][Full Text] [Related]
13. Metabolomics approach by
Zhang Y; Zhang H; Chang D; Guo F; Pan H; Yang Y
Arthritis Res Ther; 2018 Jun; 20(1):111. PubMed ID: 29871692
[TBL] [Abstract][Full Text] [Related]
14. Use of ultra high performance liquid chromatography with high resolution mass spectrometry to analyze urinary metabolome alterations following acute kidney injury in post-cardiac surgery patients.
Bai Y; Zhang H; Wu Z; Huang S; Luo Z; Wu K; Hu L; Chen C
J Mass Spectrom Adv Clin Lab; 2022 Apr; 24():31-40. PubMed ID: 35252948
[TBL] [Abstract][Full Text] [Related]
15. Investigation of pathogenesis of hyperuricemia based on untargeted and targeted metabolomics.
Qin N; Qin M; Shi W; Kong L; Wang L; Xu G; Guo Y; Zhang J; Ma Q
Sci Rep; 2022 Aug; 12(1):13980. PubMed ID: 35978088
[TBL] [Abstract][Full Text] [Related]
16. Hyperuricemia and hypertriglyceridemia indicate tubular atrophy/interstitial fibrosis in patients with IgA nephropathy and membranous nephropathy.
Liu B; Zhao L; Yang Q; Zha D; Si X
Int Urol Nephrol; 2021 Nov; 53(11):2321-2332. PubMed ID: 33895976
[TBL] [Abstract][Full Text] [Related]
17. Lipidomics coupled with pathway analysis characterizes serum metabolic changes in response to potassium oxonate induced hyperuricemic rats.
Yang F; Liu M; Qin N; Li S; Yu M; Wang C; Ma Q
Lipids Health Dis; 2019 May; 18(1):112. PubMed ID: 31077208
[TBL] [Abstract][Full Text] [Related]
18. Metabolic implications of amino acid metabolites in chronic kidney disease progression: a metabolomics analysis using OPLS-DA and MBRole2.0 database.
Kang J; Guo X; Peng H; Deng Y; Lai J; Tang L; Aoieong C; Tou T; Tsai T; Liu X
Int Urol Nephrol; 2024 Mar; 56(3):1173-1184. PubMed ID: 37728808
[TBL] [Abstract][Full Text] [Related]
19. [Lipid metabolomic analysis in exosomes of osteonecrosis of the femoral head based on ultra performance liquid chromatography-tandem mass spectrometry].
Guo M; Zhang J
Se Pu; 2022 Feb; 40(2):123-129. PubMed ID: 35080158
[TBL] [Abstract][Full Text] [Related]
20. Metabonomic Profiling Reveals Difference in Altered Metabolic Pathways Between Chronic Kidney Disease and High-Fat-Induced Insulin Resistance in Rats.
Xu Z; Zhang L; Li J; Zhao Y; Chen X
Kidney Blood Press Res; 2018; 43(4):1199-1211. PubMed ID: 30071523
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
